The Southeast Medical Device Association annual conference is right around the corner. We are excited to experience the whole of the Southeastern medtech community in Atlanta during the two day meeting, April 26-27. GCMI and its subsidiary T3 Labs share a mission with SEMDA: helping advance medtech innovation in the Southeast by bringing together the ecosystem around medtech innovators, recognizing that it really does take a village to take a device from concept to commercialization.
The reasons are many, but here is just a snapshot of why we are counting down the days until #SEMDA2017.
Networking with medtech startups innovating the Southeast
SEMDA is a critical platform for young medtech companies to pitch their idea, meet value-added investors, vendors, large medtech companies and other seasoned entrepreneurs. During the Pitch Round Roadshow, the SEMDA leadership team scoured the Southeast for top medtech talent. Thirty one startups pitched their products, but only one company from each city was selected to pitch on the main stage during SEMDA 2017.
We are excited to meet the six presenting companies and the other medical device startups that attend the flagship conference- knowing we can help them achieve their goal or inflection point be it regulatory submission, approval, preclinical services or bioskills training.
“From concept to development through clinical trials, the infrastructure needed to support successful medtech innovation resides within close proximity to our facilities,” says Tiffany Wilson, CEO of GCMI and T3 Labs. “Not to mention our new accelerator fills a gap in the ecosystem which now enables us to locally support high potential young medtech companies and the associated economics gains – including new jobs – to Atlanta and the southeast.”
Sharing our content marketing insights with the ecosystem
Our Preclinical Program Director, Deepal Panchal, acts as point person for Write2Market, GCMI and T3 Labs’ marketing arm. She is integral in the day-to-day implementation of T3’s marketing strategies and tactics. Dee will serve on a panel lead by Paul Snyder, VP of Healthcare for Write2Market, and will provide her perspective on what it takes to move the meter using value-based marketing strategies. The discussion titled “Beyond the press release: Integrated marketing strategies for medtech and med device” will take place Wednesday April 26th from 2:45 pm-3:45 pm during concurrent session #3.
Dee will sit alongside Lori Chmura, CEO of Dune Medical Devices, and Michael Krachon, Vice President of Sales & Marketing for Isoray. Together they will discuss the why, who and how of building strategic, integrated, value-based marketing programs that drive measurable results even with limited internal teams and compliance constraints.
Engaging the growing Medtech Women@SEMDA network
Tiffany Wilson, Dersi Patel, Project Engineer for GCMI, and Kelley Bennett, Program Director of Training and Education at T3 Labs, all hold board positions for Medtech Women@SEMDA, a group dedicated to enhancing opportunities for women in the medtech industry.
Though there is not programming dedicated to MW@S during SEMDA 2017, we are very excited to engage the thriving network of women who will be in attendance. MW@S is growing this year and we encourage all women in innovation and the medical device industry to attend and get involved!
Also, don’t forget to download and make use of the conference app!
Connect with GCMI and T3 Labs During #SEMDA2017
For medtech innovators seeking to bring novel technologies and therapies to life- concept to cure, through design and development, preclinical testing and FDA approval all the way to commercialization- let’s connect! Contact Deepal Panchal or Andrew Stevenson to set up a meeting during SEMDA 2017! You can find the full conference agenda here.